Sort
17,828 grants matching “crispr”
Capturing the phenotypic landscape of single-nucleotide variation via systematic genome editing
$627,527Lars M Steinmetz · Stanford University · R01 · FY2020 · GM
Capturing the phenotypic landscape of single-nucleotide variation via systematic genome editing
$627,527Lars M Steinmetz · Stanford University · R01 · FY2021 · GM
Capturing the phenotypic landscape of single-nucleotide variation via systematic genome editing
$627,527Robert St.onge · Stanford University · R01 · FY2019 · GM
Capturing the phenotypic landscape of single-nucleotide variation via systematic genome editing
$627,527Robert St.onge · Stanford University · R01 · FY2018 · GM
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link
$627,486Cornelia M Ulrich · University Of Utah · R01 · FY2023 · CA
TCR signaling regulated T cell exhaustion in response to chronic viral infection
$627,462Weiguo Cui · Northwestern University At Chicago · R01 · FY2025 · AI
Cardioprotective Therapy for Doxorubicin Using iPSC Microtissue and CRISPR Screening
$627,358Joseph C Wu · Stanford University · R01 · FY2021 · HL
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link
$627,133Cornelia M Ulrich · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
Mechanism of Acquired Immunity in Bacteria
$627,127Jennifer A Doudna · University Of California-Berkeley · · FY2010 · BIO
CSDE1 as a Post Transcriptional Regulator of the LDLR
$626,993John S Chorba · University Of California, San Francisco · R01 · FY2022 · HL
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy
$626,700Richard D Kolodner · University Of California, San Diego · R01 · FY2023 · CA
FEN1 Endonuclease as a Synthetic Lethal Target for Cancer Therapy
$626,700Richard D Kolodner · University Of California, San Diego · R01 · FY2022 · CA
C3-Dependent Intracellular Killing in Innate Immunity and Bacterial Pathogenesis
$626,584Manuela Raffatellu · University Of California, San Diego · R01 · FY2023 · AI
ChREBP in Liver Metabolism: Defining Mechanisms and Resolving Controversies
$626,429Mark A Herman · Baylor College Of Medicine · R01 · FY2025 · DK
Cell Plasticity-Based Reprogramming Strategies to Enhance Human Myocardial Regeneration
$626,400Todd K Rosengart · Baylor College Of Medicine · R01 · FY2020 · HL
Elucidating Protective Mechanisms for Cardiotoxicity of Kinase Inhibitors
$626,062Mark Mercola · Stanford University · P01 · FY2024 · HL
Binding of Epstein Barr Virus EBNA2 Unifies Multiple Sclerosis Genetic Mechanisms
$626,014Matthew Tyson Weirauch · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · NS
Emerging multidrug resistance mechanisms in Campylobacter
$626,007Qijing Zhang · Iowa State University · R01 · FY2024 · AI
Development of Next-Generation Blood-to-barcode (B2B) chip for In Vivo CRISPR-Based Discovery of Metastasis Regulators
$625,914Shana O Kelley · Northwestern University · R01 · FY2023 · CA
Development of Next-Generation Blood-to-barcode (B2B) chip for In Vivo CRISPR-Based Discovery of Metastasis Regulators
$625,914Shana O Kelley · Northwestern University · R01 · FY2025 · CA
Mechanisms and Applications of RNA-mediated Enzymes in Translation and Immunity
$625,736Hong Li · Van Andel Research Institute · R35 · FY2025 · GM
Implementing genomic medicine in clinical care of deaf patients
$625,724Xue Z Liu · University Of Miami School Of Medicine · R01 · FY2022 · DC
Family Study of Carotid Atherosclerosis and Stroke Risk
$625,704Tatjana Rundek · University Of Miami School Of Medicine · R01 · FY2019 · NS
In vivo prime editing for precision cancer mouse models
$625,607Wen Xue · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · CA
Enhancing endoplasmic reticulum stress in ovarian cancer
$625,549Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2023 · CA